Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
Rosetta Capital logo

Rosetta Capital

Europe, England, United Kingdom, London

Description

Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments.

Investor Profile

Rosetta Capital has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 14% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Sweden, Switzerland, Ireland.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (21%)
  • Series C (14%)
  • Post Ipo Equity (14%)
  • Series A (14%)
  • Post Ipo Debt (14%)
  • Series D (7%)
  • Undisclosed (7%)
  • Series B (7%)

Country Focus

  • Sweden (36%)
  • Switzerland (29%)
  • Ireland (7%)
  • United Kingdom (7%)
  • Singapore (7%)
  • Germany (7%)
  • Norway (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Medical
  • Manufacturing
  • Medical Device
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rosetta Capital frequently co-invest with?

Pfizer
Pfizer
North America, New York, United States, New York
Co-Investments: 1
Evotec
Evotec
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Partners in Equity
Partners in Equity
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3
Cambridge Innovation Capital
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
O
Ostersjöstiftelsen
Europe, Stockholms Lan, Sweden, Huddinge
Co-Investments: 2
Lightstone Ventures
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
EQT Life Sciences
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
P
Praktikerinvest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2

What are some of recent deals done by Rosetta Capital?

MISSION Therapeutics

Cambridge, Cambridgeshire, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownOct 15, 2025
Amount Raised: $13,300,000
Sequana Medical

Zürich, Zurich, Switzerland

Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo DebtSep 30, 2024
Amount Raised: $3,396,671
Sequana Medical

Zürich, Zurich, Switzerland

Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityMar 21, 2024
Amount Raised: $12,491,419
MISSION Therapeutics

Cambridge, Cambridgeshire, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series DMar 14, 2024
Amount Raised: $32,118,400
Sequana Medical

Zürich, Zurich, Switzerland

Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo DebtFeb 8, 2024
Amount Raised: $3,233,295
Carrick Therapeutics

Dublin, Dublin, Ireland

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CDec 1, 2022
Amount Raised: $60,000,000
Asarina Pharma

Solna, Stockholms Lan, Sweden

Asarina Pharma is a company targeted on developing products to treat women with severe symptoms associated with the menstrual cycle.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquitySep 20, 2018
Amount Raised: $17,096,998
Modus Therapeutics

Stockholm, Stockholms Lan, Sweden

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series UnknownFeb 20, 2017
Amount Raised: $3,579,963
Dilafor

Solna, Stockholms Lan, Sweden

Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.

BiopharmaPharmaceutical
Series UnknownSep 27, 2016
Amount Raised: $5,941,415
NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series BFeb 17, 2014
Amount Raised: $66,000,000

Find More Investors Like Rosetta Capital

Discover similar investors in our database and build your perfect investor list.

series_c InvestorsInvestors in LondonBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors
Rosetta Capital | Pipeseed